INTRAVENOUS AMODIAQUINE AND ORAL AMODIAQUINE/ERYTHROMYCIN IN THE TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA
- 1 October 1985
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 326 (8459), 805-808
- https://doi.org/10.1016/s0140-6736(85)90796-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- QUININE AND SEVERE FALCIPARUM MALARIA IN LATE PREGNANCYThe Lancet, 1985
- FAILURE OF CHLOROQUINE-ERYTHROMYCIN AND CHLOROQUINE-TETRACYCLINE COMBINATIONS IN TREATMENT OF CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN EASTERN THAILANDThe Lancet, 1984
- EFFECTIVENESS OF AMODIAQUINE AS TREATMENT FOR CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM INFECTIONS IN KENYAThe Lancet, 1984
- Treatment of Plasmodium falciparum malaria with a combination of amodiaquine and tetracycline in Central ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- DRUG SENSITIVITY OF PLASMODIUM FALCIPARUMThe Lancet, 1978
- The chemotherapy of rodent malaria, XXIVPathogens and Global Health, 1976
- Human Malaria Parasites in Continuous CultureScience, 1976
- Amodiaquine Resistant Falciparum Malaria in Thailand *The American Journal of Tropical Medicine and Hygiene, 1975
- Intravenous Amodiaquin (Camoquin 1) in Naturally Acquired and Induced MalariaThe American Journal of Tropical Medicine and Hygiene, 1951
- Parenteral Use of Camoquin Hydrochloride as an AntimalarialThe American Journal of Tropical Medicine and Hygiene, 1949